This protocol is specific to female patients of childbearing age presenting with epilepsy with eyelid myoclonia. Treatment selection in this population requires careful consideration of factors relevant to reproductive health and safety.
The protocol specifies antiseizure medication options tailored to this population. Where first-line treatment proves inadequate, the protocol defines third-line alternatives. The complete medication selection, sequencing, and clinical decision criteria are available in the full structured protocol.
DOI: 10.1111/epi.17682
There was also a strong consensus that levetiracetam (21/25, 84%) or lamotrigine (21/25, 84%) are reasonable first‑line options for women of childbearing age.
View source ↗